PTC Therapeutics, Inc. (PTCT)
PTC Therapeutics Market Cap : 5.921B for Aug. 24, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 5.921B |
| August 21, 2026 | 5.818B |
| August 20, 2026 | 5.876B |
| August 19, 2026 | 6.139B |
| August 18, 2026 | 6.052B |
| August 17, 2026 | 6.073B |
| August 14, 2026 | 5.975B |
| August 13, 2026 | 5.997B |
| August 12, 2026 | 6.053B |
| August 11, 2026 | 6.141B |
| August 10, 2026 | 6.219B |
| August 07, 2026 | 6.109B |
| August 06, 2026 | 5.904B |
| August 05, 2026 | 5.767B |
| August 04, 2026 | 5.758B |
| August 03, 2026 | 5.676B |
| July 31, 2026 | 5.667B |
| July 30, 2026 | 6.293B |
| July 29, 2026 | 6.207B |
| July 28, 2026 | 6.282B |
| July 27, 2026 | 6.282B |
| July 24, 2026 | 6.367B |
| July 23, 2026 | 6.502B |
| July 22, 2026 | 6.498B |
| July 21, 2026 | 6.506B |
| Date | Value |
|---|---|
| July 20, 2026 | 6.466B |
| July 17, 2026 | 6.514B |
| July 16, 2026 | 6.508B |
| July 15, 2026 | 6.534B |
| July 14, 2026 | 6.470B |
| July 13, 2026 | 6.741B |
| July 10, 2026 | 7.033B |
| July 09, 2026 | 7.422B |
| July 08, 2026 | 7.341B |
| July 07, 2026 | 7.393B |
| July 06, 2026 | 7.081B |
| July 02, 2026 | 6.905B |
| July 01, 2026 | 6.742B |
| June 30, 2026 | 6.761B |
| June 29, 2026 | 6.761B |
| June 26, 2026 | 6.998B |
| June 25, 2026 | 7.004B |
| June 24, 2026 | 6.996B |
| June 23, 2026 | 6.807B |
| June 22, 2026 | 6.710B |
| June 18, 2026 | 6.546B |
| June 17, 2026 | 6.509B |
| June 16, 2026 | 6.073B |
| June 15, 2026 | 6.363B |
| June 12, 2026 | 6.228B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Insmed, Inc. | 27.06B |
| Madrigal Pharmaceuticals, Inc. | 11.82B |
| Protagonist Therapeutics, Inc. | 10.01B |
| Biogen, Inc. | 32.22B |
| BioMarin Pharmaceutical, Inc. | 12.59B |
Market Cap Related Metrics
| PS Ratio | 6.029 |
| Price | 71.06 |
| Earnings Yield | -0.84% |
| Operating PE Ratio | 52.10 |